Filing Details
- Accession Number:
- 0001484612-24-000016
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-17 20:01:25
- Reporting Period:
- 2024-01-12
- Accepted Time:
- 2024-01-17 20:01:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1484612 | Outset Medical Inc. | OM | Electromedical & Electrotherapeutic Apparatus (3845) | 200514392 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1983815 | Marc Nash | 3052 Orchard Drive San Jose CA 95134 | Svp Operations And R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-01-12 | 96,000 | $0.00 | 141,233 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2024-01-12 | 100,000 | $0.00 | 241,233 | No | 4 | A | Direct | |
| Common Stock | Acquisiton | 2024-01-12 | 3,162 | $0.00 | 244,395 | No | 4 | A | Direct | |
| Common Stock | Disposition | 2024-01-16 | 678 | $429.00 | 243,717 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | A | Direct | |
| No | 4 | S | Direct |
Footnotes
- Represents restricted stock units ("RSU") granted to the reporting person on January 12, 2024. Each RSU represents a contingent right to receive one share of common stock. These RSUs shall vest 33.33% on January 12, 2025, and the remaining 66.67% shall vest in equal installments over the course of the following two years on a quarterly basis on each February 15th, May 15th, August 15th and November 15th, subject to the reporting person's continuous service through the applicable vesting date.
- This reflects the correct starting balance of directly owned shares which was incorrectly reported due to an administrative error in the original Form 3 filed on July 24, 2023.
- Represents performance-based restricted stock units ("PSUs") granted to the reporting person on January 12, 2024, that vest over a three year period based on the Issuer's common stock achieving specified prices per share, if not earlier vested upon satisfaction of specified performance criteria, subject to the reporting person's continuous service through the applicable vesting date. Each PSU represents a contingent right to receive one share of common stock.
- On January 26, 2022, the reporting person was granted performance-based restricted stock units ("PSUs") subject to the satisfaction of specified performance criteria as of December 31, 2023. The reported amount represents the number of PSUs earned by the reporting person on January 12, 2024, upon certification by the Compensation Committee of the Issuer's Board of Directors of the satisfaction of specified performance criteria. Each PSU represents a contingent right to receive one share of common stock. These PSUs vested 50% on January 12, 2024, and the remaining 50% shall vest on December 31, 2024, subject to the reporting person's continuous service through the vesting date.
- Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of PSUs on January 12, 2024 described in footnote (4) above. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Billionaire Hedge Funds
